Filing Details
- Accession Number:
- 0001415889-21-004407
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-15 17:58:33
- Reporting Period:
- 2021-09-13
- Accepted Time:
- 2021-09-15 17:58:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1790340 | Immuneering Corp | IMRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1870076 | Peter Feinberg | 245 Main Street Second Floor Cambridge MA 02142 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2021-09-13 | 5,750 | $21.51 | 392,242 | No | 4 | P | Indirect | General Partner of PF Associates L.P. |
Class A Common Stock | Acquisiton | 2021-09-13 | 349 | $21.25 | 349 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | General Partner of PF Associates L.P. |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 476,615 | Indirect | General Partner of PEF LLC. |
Class A Common Stock | 115,441 | Indirect | General Partner of S4K Investments LLC. |
Footnotes
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.08 to $22.00. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.
- This transaction was executed in multiple trades through a broker-dealer at a price of $21.25. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.